PTIX

Protagenic Therapeutics, Inc. PTIX

PTIX
Protagenic Therapeutics, Inc. LIPO
Lipella Pharmaceuticals Inc. ARTL
Artelo Biosciences, Inc. GTBP
GT Biopharma, Inc. VRAX
Virax Biolabs Group Limited AZTR
Azitra, Inc. SPRC
SciSparc Ltd. PBM
Psyence Biomedical Ltd. INDP
Indaptus Therapeutics, Inc. NKGN
NKGen Biotech, Inc. Common Stock

Résultat net

EBITDA

P/E Ratio

Capitalisation

Performance

Periode PTIX LIPO ARTL GTBP VRAX AZTR SPRC PBM INDP NKGN
6M -15.28 % -75.10 % -31.10 % -69.69 % -40.28 % -66.79 % -30.81 % 6.15 % -74.63 % -91.27 %
YTD -58.05 % -81.13 % -38.69 % -76.80 % -72.17 % -76.22 % -52.31 % -76.30 % -85.67 % -98.41 %
1Y -61.05 % -83.61 % -48.19 % -65.90 % -61.80 % -80.66 % -15.67 % -94.03 % -91.43 % -96.01 %
3Y -90.92 % -89.57 % -79.44 % -98.63 % -96.36 % -99.93 % -99.26 % -99.91 % -93.52 % -99.81 %
5Y -97.59 % -89.57 % -92.89 % -99.43 % -99.66 % -99.93 % -99.84 % -99.91 % -99.39 % -99.81 %
10Y -97.59 % -89.57 % -99.04 % -100.00 % -99.66 % -99.93 % -99.84 % -99.91 % -99.97 % -99.81 %
Depuis le début -97.59 % -89.57 % -99.04 % -100.00 % -99.66 % -99.93 % -99.84 % -99.91 % -99.97 % -99.81 %

Dividende

Protagenic Therapeutics, Inc.